{
  "id": "Ex014",
  "type": "Example",
  "informationId": {
    "id": "CritAssess288",
    "type": "CriterionAssessment",
    "criterion": {
      "id": "Crit307",
      "type": "Criterion",
      "label": "PS4",
      "description": "The prevalence of the variant in affected individuals is significantly increased compared with the prevalence in controls",
      "defaultStrength": {
        "id": "EvLnStrgID145",
        "type": "EvidenceLineStrength",
        "label": "Pathogenic Strong"
      }
    },
    "variant": {
      "id": "CanAll023",
      "type": "CanonicalAllele",
      "preferredCtxAllele": {
        "id": "CtxAll026",
        "type": "ContextualAllele",
        "relatedCanonicalAllele": "CanAll023",
        "alleleName": "NM_000540.2 (RYR1):c.1840C>T"
      }
    },
    "condition": [
      {
        "id": "GenCond011",
        "type": "GeneticCondition",
        "disease": [
          {
            "id": "DisID172",
            "type": "Disease",
            "label": "Malignant hyperthermia"
          }
        ],
        "modeOfInheritance": {
          "id": "ModeOfInhID051",
          "type": "ModeOfInheritance",
          "label": "Autosomal Dominant"
        }
      }
    ],
    "outcome": {
      "id": "CritEvalID074",
      "type": "CriterionEvaluation",
      "label": "Met"
    },
    "evidenceLine": [
      {
        "id": "EvLn020",
        "type": "EvidenceLine",
        "evidenceItem": [
          {
            "id": "CaseCtrl033",
            "type": "CaseControl",
            "canonicalAllele": {
              "id": "CanAll023",
              "type": "CanonicalAllele",
              "preferredCtxAllele": {
                "id": "CtxAll026",
                "type": "ContextualAllele",
                "relatedCanonicalAllele": "CanAll023",
                "alleleName": "NM_000540.2 (RYR1):c.1840C>T"
              }
            },
            "condition": {
              "id": "GenCond011",
              "type": "GeneticCondition",
              "disease": [
                {
                  "id": "DisID172",
                  "type": "Disease",
                  "label": "Malignant hyperthermia"
                }
              ],
              "modeOfInheritance": {
                "id": "ModeOfInhID051",
                "type": "ModeOfInheritance",
                "label": "Autosomal Dominant"
              }
            },
            "caseGroupFrequency": {
              "id": "AllFreq032",
              "type": "AlleleFrequency",
              "allele": {
                "id": "CanAll023",
                "type": "CanonicalAllele",
                "preferredCtxAllele": {
                  "id": "CtxAll026",
                  "type": "ContextualAllele",
                  "relatedCanonicalAllele": "CanAll023",
                  "alleleName": "NM_000540.2 (RYR1):c.1840C>T"
                }
              },
              "description": "This allele is thought to account for between 2% and 10% of patients with Malignant hyperthermia."
            },
            "controlGroupFrequency": {
              "id": "AllFreq031",
              "type": "AlleleFrequency",
              "ascertainment": {
                "id": "AscrtID203",
                "type": "Ascertainment",
                "label": "ExAc ascertainment method"
              },
              "allele": {
                "id": "CanAll023",
                "type": "CanonicalAllele",
                "preferredCtxAllele": {
                  "id": "CtxAll026",
                  "type": "ContextualAllele",
                  "relatedCanonicalAllele": "CanAll023",
                  "alleleName": "NM_000540.2 (RYR1):c.1840C>T"
                }
              },
              "alleleCount": 9,
              "alleleNumber": 66740
            },
            "description": "Did not calculate formal odds ratio"
          }
        ]
      }
    ],
    "contribution": [
      {
        "type": "Contribution",
        "agent": {
          "id": "Agent001",
          "type": "Agent",
          "label": "Harry Stevenson"
        },
        "contributionDate": "6/5/16 2:39 PM",
        "contributionRole": {
          "id": "ContribRoleID193",
          "type": "ContributoryRole",
          "label": "assessor role"
        }
      }
    ],
    "description": "Across publications, this variant is thought to account for 2%-10% of patients with Malignant hyperthermia. But variant is also only found in 9/66740 Europeans in ExAC (.01%). Based on these differences, groups applied PS4 to this variant classification (without a formal OR analysis)."
  },
  "index": 2,
  "author": "Steven Harrison",
  "description": "Assessed variant: NM_000540.2 (RYR1):c.1840C>T (p.Arg614Cys)\n \nAcross publications, this variant is thought to account for 2%-10% of patients with Malignant hyperthermia. But variant is also only found in 9/66740 Europeans in ExAC (.01%). Based on these differences, groups applied PS4 to this variant classification (without a formal OR analysis)."
}
